Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun 3,4-diaminopyridine, an organic compound used in the treatment of a number of rare muscle diseases.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word amifampridine.

Examples

  • Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS).

    unknown title 2011

  • Germany; and Firdapse™ amifampridine phosphate, which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic

    BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease - Yahoo! Finance 2011

  • BioMarin Pharmaceutical receives marketing approval for amifampridine phosphate

    THE MEDICAL NEWS 2010

  • Firdapse (TM) (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS).

    RedOrbit News - Technology 2010

  • Potential stem cells treatment for retinitis pigmentosa and other retinal degenerations BioMarin Pharmaceutical receives marketing approval for amifampridine phosphate >

    THE MEDICAL NEWS 2010

  • BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).

    THE MEDICAL NEWS 2010

  • Germany; and Firdapse ™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS).

    Medindia Health News 2010

  • Germany; and Firdapse (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic

    BioSpace.com Featured News and Stories 2010

  • Germany; and Firdapse ™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS).

    Medindia Health News 2010

  • Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic

    BioMarin to Host Third Quarter 2010 Financial Results Conference Call and Webcast on Thursday, October 28 at 5:00 p.m. ET - Yahoo! Finance 2010

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.